ST. LOUIS – A new drug therapy has been administered at SSM Health hospitals since June 2021 that is proving to dissolve blood clots, particularly larger clots, in a shorter amount of time. Normally, ...
Apr. 14—URBANA — For decades, hospitals have treated strokes caused by blood clots with the standard clot-busting drug alteplase. Now, OSF HealthCare hospitals have joined several others that have ...
Tissue plasminogen activator (tPA) is a medication that doctors administer following a stroke caused by a blood clot. It breaks up the blood clot to allow blood flow to return to the brain. The ...
We conducted a trial at 41 academic tertiary care centers in China to evaluate endovascular thrombectomy with or without intravenous alteplase in patients with acute ischemic stroke. Patients with ...
The value of administering intravenous alteplase before endovascular treatment (EVT) for acute ischemic stroke has not been studied extensively, particularly in non-Asian populations. We performed an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results